Learn More
CERILLIANT™ Dehydroepiandrosterone-D5 (DHEA-D5) (2,2,3,4,4-D5) Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco D0641ML
Description
An internal standard suitable for LCMS and GCMS applications in clinical and sports testing environments. In addition to testing under the World Anti-Doping Code of the World Anti-Doping Agency (WADA), DHEA levels are also measured for newborn screening of congential adrenal hyperplasia (CAH) and for determination of hyperandrogenic conditions such as polycystic ovarian syndrome and adrenal tumors.
Specifications
| 67-56-1 , 97453-25-3 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| DHEAS-D5 (2,2,3,4,4-D5), Dehydroepiandrosterone-d5 (2,2,3,4,4-d5) | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
| C19H23D5O2 | |
| 100 μg/mL in methanol | |
| 293.46 | |
| 1 mL |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : 2 to 8°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation